Dynavax Technologies Corp Sees 3.7% Surge, Analysts Predict 129.92% Upside

Dynavax Technologies Corp's (DVAX) stock surged 3.7% to $10.36 on June 18, with trading volume at 1.43 million shares. Analysts forecast an average target price of $23.82, implying a 129.92% upside from the current price. The estimated GF Value is $14.87, suggesting a 43.53% upside. Based on consensus recommendation from 6 brokerage firms, DVAX's average brokerage recommendation is 2.2, indicating "Outperform" status.

Dynavax Technologies Corp (DVAX) stock surged 3.7% to $10.36 on June 18, with trading volume at 1.43 million shares. The stock reached an intraday high of $10.68 before settling at $10.36, up from its previous close of $9.99. This places DVAX 29.19% below its 52-week high of $14.63 and 12.36% above its 52-week low of $9.22 [2].

Analysts forecast an average target price of $23.82, implying a 129.92% upside from the current price of $10.36. The average target price is based on the one-year price targets offered by 5 analysts, with a high estimate of $31.00 and a low estimate of $11.10 [2].

The estimated GF Value for Dynavax Technologies Corp is $14.87, suggesting a 43.53% upside from the current price of $10.36. The GF Value is GuruFocus' estimate of the fair value that the stock should be traded at, calculated based on historical multiples and future estimates of business performance [2].

Based on the consensus recommendation from 6 brokerage firms, Dynavax Technologies Corp's average brokerage recommendation is 2.2, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies a Strong Buy and 5 denotes a Sell [2].

References:
[1] https://stockinvest.us/stock/DVAX
[2] https://www.gurufocus.com/news/2934794/dynavax-technologies-corp-dvax-trading-37-higher-on-jun-18